| | |

Breaking Down Mesothelioma: Diagnosis and Treatment Options

Breaking Down Mesothelioma: Diagnosis and Treatment Options

An international team of scientists from India, Malaysia, and Indonesia published an overview of the diagnosis and treatment of mesothelioma.

Their report was published in the scientific journal Frontiers in Oncology.

Understanding Mesothelioma Diagnosis and Treatment

Mesothelioma is a rare and aggressive tumor that grows in the lining of certain body cavities. It usually happens in the chest, abdomen, or around the heart.

Mesothelioma is caused by exposure to asbestos, a harmful substance that was once used in many industries. Even though asbestos is now banned in many places, the number of mesothelioma cases is still increasing.

Diagnosing mesothelioma is challenging because it can look like more common diseases. To diagnose mesothelioma, doctors often use imaging tests like X-rays, CT scans, MRIs, and PET scans. They might also use biopsies and blood tests.

A Collaborative Effort to Conquer Mesothelioma

Treatment options usually include surgery, chemotherapy, radiation therapy. Most treatments available today are not very effective. The average life expectancy after diagnosis is only around 10 to 12 months.

To improve the diagnosis of mesothelioma, scientists have been trying to understand what causes this disease within the body. One pathway being studied is the “hippo signaling pathway”, which is related to certain genetic changes that contribute to the development of mesothelioma.

Scientists are also looking for better ways to treat mesothelioma. One way is by exploring cancer vaccines. This type of treatment tries to get the body’s immune system to attack cancer cells. Some small studies have shown that some cancer vaccines can be safe and effective, but larger studies are needed.

Another treatment that scientists are studying is called adoptive T-cell treatment. This is a type of immunotherapy that boosts a person’s T cells to be better at destroying cancer cells. A version of adoptive T-cell treatment called CAR-T cell therapy has been effective at treating relapsed leukemia and lymphoma.

Scientists are doing a lot of interesting and ground-breaking research in ways to improve the diagnosis and treatment of mesothelioma. With any luck, some of these new ideas will improve the outlook for patients with this disease.

Source

Sahu RK, Ruhi S, Jeppu AK, et al. Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies. Front Oncol. 2023;13:1204722. Published 2023 Jul 4. doi:10.3389/fonc.2023.1204722. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353315/

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…